Evaluation of Healthcare Utilisation and Expenditures in Persons with Type 2 Diabetes Undergoing Bariatric-Metabolic Surgery.
Valerie M MonpellierRose J GeurtenIgnace M C JanssenDirk RuwaardJeroen N StruijsPeter R van DijkHenk J G BiloArianne Mathilda Josephus ElissenPublished in: Obesity surgery (2024)
BMS in people with T2DM stabilises healthcare expenditures and decreases medication use and care use for microvascular complications. In contrast, healthcare use and expenditures in T2DM patients who do not undergo surgery gradually increase over time. Due to the progressive nature of T2DM, it is expected that these differences will become larger in the long-term.
Keyphrases
- healthcare
- minimally invasive
- coronary artery bypass
- health insurance
- multiple sclerosis
- magnetic resonance
- palliative care
- glycemic control
- surgical site infection
- type diabetes
- health information
- magnetic resonance imaging
- pain management
- skeletal muscle
- metabolic syndrome
- coronary artery disease
- atrial fibrillation
- percutaneous coronary intervention
- obese patients